Stanford inventors have developed a near infrared (NIR) tumor imaging platform that couples a novel rare earth cancer targeting agent and a handheld NIR-IIb fluorescence imager to enable tumor resection down to the few-cell level.
Stanford researchers in the Dai Lab have developed the first ultra-bright cubic-phase erbium-based rare-earth nanoparticles (α-ErNPs) with down-shifting luminescence at ~ 1600 nm for in vivo NIR-IIb (1500-1700 nm) imaging with deep penetration and high clarity.
Stanford researchers have proposed a novel, in vivo, real-time epifluorescence imaging method in the second near-infrared region using single-walled carbon nanotubes (SWNTs).